Concerns about intracavitary chemotherapy.
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003131:Combined Modality Therapy; D006801:Humans; D007263:Infusions, Parenteral / Q000009:adverse effects; D010534:Peritoneal Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents